 |
 |
 |
 |
|
 |
Showing Treatment 1 to 25 of 75 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
Phase I/II Trial for Patients with Recurrent Resectable Glioblastoma Multiforme Using Surgery with Implantable BCNU Polmer Followed by Post-operative Irinotecan and Bevacizumab |
 |
Cincinnati, OH USA |
 |
08/27/2009 |
 |
 |
 |
 |
 |
Details |
 |
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
 |
Cincinnati, OH USA |
 |
08/27/2009 |
 |
 |
 |
Details |
 |
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
 |
San Francisco, CA USA |
 |
07/07/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Back up Stereotactic Radiation Therapy |
 |
Cincinnati, OH USA |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Dallas, TX USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Tampa, FL USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Summit, NJ USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Cleveland, OH USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Los Angeles, CA USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Columbus, OH USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Chicago, IL USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Ann Arbor, MI USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Minneapolis, MN USA |
 |
03/15/2009 |
 |
 |
 |
 |
 |
Details |
 |
Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer |
 |
Rochester, NY USA |
 |
03/15/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Durham, NC USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
New York, NY USA |
 |
03/04/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Tampa, FL USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
03/04/2009 |
 |
 |
 |
Details |
 |
The GLASS-ART Trial: A Phase III Randomized Study of Neuradiab in Combination With External Beam Radiation and Temozolomide Versus External Beam Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
Omaha, NE USA |
 |
03/04/2009 |
 |
 |
 |
 |
 |
Details |
 |
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
 |
Santa Monica, CA USA |
 |
11/29/2008 |
 |
 |
 |
Details |
 |
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
 |
Cleveland, OH USA |
 |
11/19/2008 |
 |
 |
 |
 |
 |
Details |
 |
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
 |
Cleveland, OH USA |
 |
11/19/2008 |
 |
 |
 |
Details |
 |
AutoLITT™ FIM Trial - A Prospective First-In-Man (FIM) Safety Trial of the AutoLITT Laser Treatment of Recurrent/Progressive Brain Tumors |
 |
Cleveland, OH USA |
 |
09/28/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status |
 |
New York, NY USA |
 |
11/08/2007 |
 |
 |
 |
 |
 |